No registrations found.
ID
Source
Brief title
Health condition
Colorectal cancer
Lifestyle
Diet
Physical activity
Body composition
Health-related quality of life
Prognosis
Sponsors and support
Maastricht University Medical Center
World Cancer Research Fund International
Kankeronderzoekfonds Limburg
TRANSCAN / European Research Area Network (ERA-NET)
Intervention
Outcome measures
Primary outcome
Several patient-reported outcomes, including:
- health-related quality of life
- functioning and disability
- fatigue
- peripheral neuropathy
- depression and anxiety
Secondary outcome
- Prognostic outcomes (survival, recurrence)
- Treatment-related adverse effects / toxicity
Background summary
The EnCoRe study is a multicenter prospective cohort study, ongoing since 2012. The study primarily aims to investigate associations of factors related to diet, physical activity and body composition with health-related quality of life, functioning, and prognosis of colorectal cancer survivors, including the molecular/genetic mechanisms involved.
Study objective
The EnCoRe study investigates the role of lifestyle and related factors (diet, physical activity, body composition) on the health, functioning, quality of life, and prognosis of colorectal cancer survivors.
Study design
Newly diagnosed colorectal cancer patients are longitudinally followed up in the EnCoRe study from diagnosis until 5 years after the end of cancer treatment, with repeated measurementrs at the following timepoints:
T1 - At diagnosis (pre-treatment)
T2 - 6 weeks post-treatment
T3 - 6 months post-treatment
T4 - 1 year post-treatment
T5 - 2 years post-treatment
T6 - 5 years post-treatment
Intervention
Not applicable.
The EnCoRe study is an observational study
(multicenter prospective cohort study).
GROW - School for Oncology & Developmental Biology
Maastricht University
MJL Bours
PO Box 616
Maastricht 6200 MD
The Netherlands
m.bours@maastrichtuniversity.nl
GROW - School for Oncology & Developmental Biology
Maastricht University
MJL Bours
PO Box 616
Maastricht 6200 MD
The Netherlands
m.bours@maastrichtuniversity.nl
Inclusion criteria
Dutch men and women (>18y) diagnosed with stage I-III colorectal cancer, including recurrent cancer.
Exclusion criteria
- Stage IV colorectal cancer
- Comorbidities obstructing participation (e.g. Alzheimer's disease)
Design
Recruitment
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL6904 |
NTR-old | NTR7099 |
CCMO | NL38786.068.11 |
OMON | NL-OMON53143 |